|
⚲
|
| Vivo Ventures VII LLC | |
|---|---|
| Firm | Vivo Capital LLC |
| Address | 575 High Street, Suite 201 Palo Alto, CA 94301 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Vivo Capital LLC | |||||
| Vivo Ventures Fund VII LP | 021-152838 | Promoter | of 350.0 M |
7.8 | |
| Vivo Ventures VII Affiliates Fund LP | 021-171042 | Promoter | 6.4 M of 6.4 M |
0.4 | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ProNAi Therapeutics Inc SRRA
Series A Warrants · derivative
|
2022-07-01 | Disposed to issuer | 75,749 | $0.00 | |
|
ProNAi Therapeutics Inc SRRA
Common Stock
|
2022-07-01 | Disposed to issuer | 161,712 | $55.00 | 8,894,160 |
|
ProNAi Therapeutics Inc SRRA
Common Stock
|
2022-07-01 | Disposed to issuer | 431,947 | $55.00 | 23,757,085 |
|
ProNAi Therapeutics Inc SRRA
Common Stock
|
2022-07-01 | Disposed to issuer | 2,735,853 | $55.00 | 150,471,915 |
|
ProNAi Therapeutics Inc SRRA
Series A Warrants · derivative
|
2022-07-01 | Disposed to issuer | 1,455,384 | $0.00 | |
|
ProNAi Therapeutics Inc SRRA
Series A Warrants · derivative
|
2022-07-01 | Disposed to issuer | 324,740 | $0.00 | |
|
ProNAi Therapeutics Inc SRRA
Common Stock
|
2022-01-31 | Buy | 800,000 | $27.00 | 21,600,000 |
|
ProNAi Therapeutics Inc SRRA
Series B Warrant (Right to Purchase ) · derivative
|
2022-01-26 | Option exercise | 1,455,384 | $13.20 | 19,211,069 |
|
ProNAi Therapeutics Inc SRRA
Series B Warrant (Right to Purchase ) · derivative
|
2022-01-26 | Option exercise | 324,740 | $13.20 | 4,286,568 |
|
ProNAi Therapeutics Inc SRRA
Series B Warrant (Right to Purchase ) · derivative
|
2022-01-26 | Option exercise | 75,749 | $13.20 | 999,887 |
|
ProNAi Therapeutics Inc SRRA
Common Stock
|
2022-01-26 | Option exercise | 107,164 | $13.20 | 1,414,565 |
|
ProNAi Therapeutics Inc SRRA
Common Stock
|
2022-01-26 | Option exercise | 24,996 | $13.20 | 329,947 |
|
ProNAi Therapeutics Inc SRRA
Common Stock
|
2022-01-26 | Option exercise | 480,277 | $13.20 | 6,339,656 |
|
ProNAi Therapeutics Inc SRRA
Common Stock
|
2020-01-29 | Conversion | 324,783 | $0.00 | |
|
ProNAi Therapeutics Inc SRRA
Series A Convertible Voting Preferred Stock · derivative
|
2020-01-29 | Conversion | 1,000 | ||
|
ProNAi Therapeutics Inc SRRA
Series A Convertible Voting Preferred Stock · derivative
|
2020-01-29 | Conversion | 4,287 | ||
|
ProNAi Therapeutics Inc SRRA
Series A Convertible Voting Preferred Stock · derivative
|
2020-01-29 | Conversion | 19,213 | ||
|
ProNAi Therapeutics Inc SRRA
Common Stock
|
2020-01-29 | Conversion | 1,455,576 | $0.00 | |
|
ProNAi Therapeutics Inc SRRA
Common Stock
|
2020-01-29 | Conversion | 75,759 | $0.00 | |
|
Airxpanders Inc AXP
Common Stock
|
2018-08-30 | Buy | 19,712,492 | $0.17 | 3,351,124 |
| showing 20 of 76 most recent transactions | |||||